Proteomics at a Crossroads: Why We Must Rethink Data Analysis
Proteomics is on the verge of a transformation. The depth and scale...
Pioneering Multivariate Companion Markers: Collaborative Pathways to Accelerate Market Access
Multivariate companion markers (MCMs) hold the key to unlocking...
Transforming Drug Discovery: The Critical Role of Proteomics and Targeted Protein Degradation in the Future of Therapeutics
Dr. Andrew I Webb explores how advanced proteomics and Targeted...
Coffees, conversations, and negotiations: an energizing day @ FeMS “Out Of The Shadows” Workshop
How we learnt to increase executive presence, harness the power of...
ASMS 2024: The rise of Automation and AI-Driven Raw MS Data Processing Solutions
72nd Conference on Mass Spectrometry and Allied Topics. Anaheim...
Proteomics Progression: Insights and Inflection Points
A Redwood City evening with Key Opinion Leaders, exploring insights...
What's New? Q2-23
More new features to breakthrough bottlenecks: protein abundance...
The Future of Scientific Progress: From Academia to Industry and the Rise of Digital Biology
The future is bright, and it starts with a willingness to adapt,...
What's New? Q1-23
Bruker Launches de novo Sequencing for Immunopeptidomics,...
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
Bruker Launches de novo Sequencing for Immunopeptidomics,...
Dec-22 - #massgeek Playbook Special HUPO 2022 Edition
If you are new to the MassGeek Community, welcome! We're so glad...
MD 2.0 unleashes next level MSP insight generation (Part 2)
In my opinion, MSP is one of the most exciting areas in biological...
